The interleukin-7 (IL7) ligand has been previously implicated as an inducer of tumor growth in lymphoblastic leukemia [10], prostate cancer [11], breast cancer [12], and colorectal cancer [13]. The gene discussed is IL7; the disease is prostate carcinoma.